Abstract
The integration between molecular biology and clinical practice requires the achievement of fundamental steps to link basic science to diagnosis and management of patients. In the last decade, the study of genetic bases of human diseases has achieved several milestones, and it is now possible to apply the knowledge that stems fromthe identification of the genetic substrate of diseases to clinical practice. The first step along the process of linking molecular biology to clinical medicine is the identification of the genetic bases of inherited diseases. After this important goal is achieved, it becomes possible to extend research to understand the functional impairments of mutant protein(s) and to link them to clinical manifestations (genotype-phenotype correlation). In genetically heterogeneous diseases, it may be possible to identify locus-specific risk stratification and management algorithms. Finally, the most ambitious step in the study of genetic disease is to discover a novel pharmacological therapy targeted at correcting the inborn defect (locus-specific therapy) or even to “cure” the DNA abnormality by replacing the defective gene with gene therapy. At present, this curative goal has been successful only for very few diseases. In the field of inherited arrhythmogenic diseases, several genes have been discovered, and genetics is now emerging as a source of information contributing not only to a better diagnosis but also to risk stratification and management of patients. The functional characterization of mutant proteins has opened new perspectives about the possibility of performing genespecific or mutation-specific therapy. In this chapter, we will briefly summarize the genetic bases of inherited arrhythmogenic conditions and we will point out how the information derived from molecular genetics has influenced the “optimal use of traditional therapies” and has paved the way to the development of gene-specific therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abbott GW, Sesti F, Splawski I, Buck ME, Lehmann MH, Timothy KW, Keating MT, Goldstein SA (1999) MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 97:175–187
Ackerman MJ, Clapham DE (1997) Ion channels—basic science and clinical disease. N Engl J Med 336:1575–1586
Ahlquist RP (1948) A study of the adrenotropic receptors. Am J Physiol 153:586–600
Anonymous (1981) Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 304:801–807
Anonymous (1982) A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 247:1707–1714
Anonymous (1999a) Effect ofmetoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353:2001–2007
Anonymous (1999b) The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 353:9–13
Antzelevitch C (2003) Molecular genetics of arrhythmias and cardiovascular conditions associated with arrhythmias. Pacing Clin Electrophysiol 26:2194–2208
Arch JR, Kaumann AJ (1993) Beta 3 and atypical beta-adrenoceptors. Med Res Rev 13:663–729
Bahinski A, Nairn AC, Greengard P, Gadsby DC (1989) Chloride conductance regulated by cyclic AMP-dependent protein kinase in cardiac myocytes. Nature 340:718–721
Barcroft H, Talbot JF (1968) Oliver and Schafer’s discovery of the cardiovascular action of suprarenal extract. Postgrad Med J 44:6–8
Barhanin J, Lesage F, Guillemare E, Fink M, Lazdunski M, Romey G (1996) K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current. Nature 384:78–80
Belardinelli L, Isenberg G (1983) Actions of adenosine and isoproterenol on isolated mammalian ventricular myocytes. Circ Res 53:287–297
Beuckelmann DJ, Nabauer M, Erdmann E (1993) Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res 73:379–385
Bigger JT Jr (1985) Digitalis toxicity. J Clin Pharmacol 25:514–521
Bohm M, Diet F, Feiler G, Kemkes B, Erdmann E (1988) Alpha-adrenoceptors and alpha-adrenoceptor-mediated positive inotropic effects in failing human myocardium. J Cardiovasc Pharmacol 12:357–364
Bonet S, Agusti A, Arnau JM, Vidal X, Diogene E, Galve E, Laporte JR (2000) Beta-adrenergic blocking agents in heart failure: benefits of vasodilating and non-vasodilating agents according to patients’ characteristics: a meta-analysis of clinical trials. Arch Intern Med 160:621–627
Boutitie F, Boissel JP, Connolly SJ, Camm AJ, Cairns JA, Julian DG, Gent M, Janse MJ, Dorian P, Frangin G (1999) Amiodarone interaction with beta-blockers: analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases. The EMIAT and CAMIAT Investigators. Circulation 99:2268–2275
Bristow MR, Minobe WA, Raynolds MV, Port JD, Rasmussen R, Ray PE, Feldman AM (1993) Reduced beta 1 receptor messenger RNA abundance in the failing human heart. J Clin Invest 92:2737–2745
Brodde OE (1991) Beta 1-and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 43:203–242
Brodde OE, Vogelsang M, Broede A, Michel-Reher M, Beisenbusch-Schafer E, Hakim K, Zerkowski HR (1998) Diminished responsiveness of Gs-coupled receptors in severely failing human hearts: no difference in dilated versus ischemic cardiomyopathy. J Cardiovasc Pharmacol 31:585–594
Burnell RH, Maxwell GM (1971) The cardiovascular effects of terbutaline. Eur J Pharmacol 15:383–385
Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR Jr, Trendelenburg U (1994) International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev 46:121–136
Cairns JA, Connolly SJ, Roberts R, Gent M (1997) Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet 349:675–682
Cameron JS, Myerburg RJ, Wong SS, Gaide MS, Epstein K, Alvarez TR, Gelband H, Guse PA, Bassett AL (1983) Electrophysiologic consequences of chronic experimentally induced left ventricular pressure overload. J Am Coll Cardiol 2:481–487
CAST Investigators (1989) Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N Engl J Med 321:406–412
Chen SA, Chiang CE, Yang CJ, Cheng CC, Wu TJ, Wang SP, Chiang BN, Chang MS (1994) Sustained atrial tachycardia in adult patients. Electrophysiological characteristics, pharmacological response, possible mechanisms, and effects of radiofrequency ablation. Circulation 90:1262–1278
Chen SA, Hsieh MH, Tai CT, Tsai CF, Prakash VS, Yu WC, Hsu TL, Ding YA, Chang MS (1999) Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 100:1879–1886
Cleophas TJ, Zwinderman AH (2001) Beta-blockers and heart failure: meta-analysis of mortality trials. Int J Clin Pharmacol Ther 39:383–388
Connolly SJ, Cybulsky I, Lamy A, Roberts RS, O’Brien B, Carroll S, Crystal E, Thorpe KE, Gent M (2003) Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta-Blocker Length Of Stay (BLOS) study. Am Heart J 145:226–232
Courtemanche M, Ramirez RJ, Nattel S (1999) Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: insights from a mathematical model. Cardiovasc Res 42:477–489
Cranefield PF (1977) Action potentials, afterpotentials, and arrhythmias. Circ Res 41:415–423
Cranefield PF, Wit AL, Hoffman BF (1973) Genesis of cardiac arrhythmias. Circulation 47:190–204
Crystal E, Connolly SJ, Sleik K, Ginger TJ, Yusuf S (2002) Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis. Circulation 106:75–80
Cui J, Melman Y, Palma E, Fishman GI, McDonald TV (2000) Cyclic AMP regulates the HERG K(+) channel by dual pathways. Curr Biol 10:671–674
Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT (1995) A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 80:795–803
De Ferrari GM, Viola MC, D’Amato E, Antolini R, Forti S (1995) Distinct patterns of calcium transients during early and delayed afterdepolarizations induced by isoproterenol in ventricular myocytes. Circulation 91:2510–2515
De Rosa G, Delogu AB, Piastra M, Chiaretti A, Bloise R, Priori SG (2004) Catecholaminergic polymorphic ventricular tachycardia: successful emergency treatment with intravenous propranolol. Pediatr Emerg Care 20:175–177
DiFrancesco D (1993) Pacemaker mechanisms in cardiac tissue. Annu Rev Physiol 55:455–472
Dixon RA, Kobilka BK, Strader DJ, Benovic JL, Dohlman HG, Frielle T, Bolanowski MA, Bennett CD, Rands E, Diehl RE (1986) Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin. Nature 321:75–79
Dresel PE (1960) Blockade of some cardiac actions of adrenaline by dichloroisoproterenol. Can J Med Sci 38:375–381
Dzimiri N (1999) Regulation of beta-adrenoceptor signaling in cardiac function and disease. Pharmacol Rev 51:465–501
Egan TM, Noble D, Noble SJ, Powell T, Twist VW, Yamaoka K (1988)On the mechanism of isoprenaline-and forskolin-induced depolarization of single guinea-pig ventricular myocytes. J Physiol 400:299–320
Eichhorn EJ, Bristow MR (1996) Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. Circulation 94:2285–2296
Eichhorn EJ, Bristow MR (2001) The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Curr Control Trials Cardiovasc Med 2:20–23
Engelhardt S, Bohm M, Erdmann E, Lohse MJ (1996) Analysis of beta-adrenergic receptor mRNA levels in human ventricular biopsy specimens by quantitative polymerase chain reactions: progressive reduction of beta 1-adrenergic receptor mRNA in heart failure. J Am Coll Cardiol 27:146–154
Fabiato A, Fabiato F (1975) Contractions induced by a calcium-triggered release of calcium from the sarcoplasmic reticulum of single skinned cardiac cells. J Physiol 249:469–495
Fakler B, Brandle U, Glowatzki E, Zenner HP, Ruppersberg JP (1994) Kir2.1 inward rectifier K+ channels are regulated independently by protein kinases and ATP hydrolysis. Neuron 13:1413–1420
Fedida D, Wible B, Wang Z, Fermini B, Faust F, Nattel S, Brown AM (1993) Identity of a novel delayed rectifier current from human heart with a cloned K+ channel current. Circ Res 73:210–216
Feng J, Wible B, Li GR, Wang Z, Nattel S (1997) Antisense oligodeoxynucleotides directed against Kv1.5 mRNA specifically inhibit ultrarapid delayed rectifier K+ current in cultured adult human atrial myocytes. Circ Res 80:572–579
Freemantle N, Cleland J, Young P, Mason J, Harrison J (1999) beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 318:1730–1737
Gaspo R, Bosch RF, Talajic M, Nattel S (1997) Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model. Circulation 96:4027–4035
Gelband H, Bassett AL (1973) Depressed transmembrane potentials during experimentally induced ventricular failure in cats. Circ Res 32:625–634
Goldstein S, Hjalmarson A (1999) The mortality effect of metoprolol CR/XL in patients with heart failure: results of the MERIT-HF Trial. Clin Cardiol 22 Suppl 5:V30–V35
Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659–666
Hakim K, Fischer M, Gunnicker M, Poenicke K, Zerkowski HR, Brodde OE (1997) Functional role of beta2-adrenoceptors in the transplanted human heart. J Cardiovasc Pharmacol 30:811–816
Han W, Chartier D, Li D, Nattel S (2001a) Ionic remodeling of cardiac Purkinje cells by congestive heart failure. Circulation 104:2095–2100
Han W, Wang Z, Nattel S (2001b) Slow delayed rectifier current and repolarization in canine cardiac Purkinje cells. Am J Physiol Heart Circ Physiol 280:H1075–H1080
Harvey RD, Hume JR (1989) Autonomic regulation of a chloride current in heart. Science 244:983–985
Hauswirth O, Noble D, Tsien RW (1968) Adrenaline: mechanism of action on the pacemaker potential in cardiac Purkinje fibers. Science 162:916–917
Hjalmarson A, Gilpin EA, Kjekshus J, Schieman G, Nicod P, Henning H, Ross J Jr (1990) Influence of heart rate on mortality after acute myocardial infarction. Am J Cardiol 65:547–553
Hohnloser SH (1997) Proarrhythmia with class III antiarrhythmic drugs: types, risks, and management. Am J Cardiol 80:82G–89G
Hume JR, Duan D, Collier ML, Yamazaki J, Horowitz B (2000) Anion transport in heart. Physiol Rev 80:31–81
Hwang TC, Horie M, Nairn AC, Gadsby DC (1992) Role of GTP-binding proteins in the regulation of mammalian cardiac chloride conductance. J Gen Physiol 99:465–489
Ihl-Vahl R, Eschenhagen T, Kubler W, Marquetant R, Nose M, Schmitz W, Scholz H, Strasser RH (1996) Differential regulation of mRNA specific for beta 1-and beta 2-adrenergic receptors in human failing hearts. Evaluation of the absolute cardiac mRNA levels by two independent methods. J Mol Cell Cardiol 28:1–10
ISIS Collaborative Group (1986) Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. Lancet 2:57–66
ISIS Collaborative Group (1988) Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction: ISIS-1. ISIS-1 (First International Study of Infarct Survival) Collaborative Group. Lancet 1:921–923
Janse MJ, Wit AL (1989) Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol Rev 69:1049–1169
January CT, Riddle JM (1989) Early afterdepolarizations: mechanism of induction and block. A role for L-type Ca2+ current. Circ Res 64:977–990
Julian DG, Camm AJ, Frangin G, Janse MJ, Munoz A, Schwartz PJ, Simon P (1997) Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Lancet 349:667–674
Kaab S, Nuss HB, Chiamvimonvat N, O’Rourke B, Pak PH, Kass DA, Marban E, Tomaselli GF (1996) Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ Res 78:262–273
Katz AM (2003) Pathophysiology of heart failure: identifying targets for pharmacotherapy. Med Clin North Am 87:303–316
Katzung BG, Morgenstern JA (1977) Effects of extracellular potassium on ventricular automaticity and evidence for a pacemaker current in mammalian ventricular myocardium. Circ Res 40:105–111
Kaumann AJ (1996) (—)-CGP 12177-induced increase of human atrial contraction through a putative third beta-adrenoceptor. Br J Pharmacol 117:93–98
Kaumann AJ, Hall JA, Murray KJ, Wells FC, Brown MJ (1989) A comparison of the effects of adrenaline and noradrenaline on human heart: the role of beta 1-and beta 2-adrenoceptors in the stimulation of adenylate cyclase and contractile force. Eur Heart J 10 Suppl B:29–37
Keating MT, Sanguinetti MC (2001) Molecular and cellular mechanisms of cardiac arrhythmias. Cell 104:569–580
Kelman GR, Palmer KN, Cross MR (1969) Cardiovascular effects of AH.3365 (salbutamol). Nature 221:1251
Khan MI, Hamilton JT, Manning GW (1972) Protective effect of beta adrenoceptor blockade in experimental coronary occlusion in conscious dogs. Am J Cardiol 30:832–837
Kjekshus JK (1986) Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol 57:43F–49F
Kleiman RB, Houser SR (1989) Outward currents in normal and hypertrophied feline ventricular myocytes. Am J Physiol 256:H1450–H1461
Koumi S, Backer CL, Arentzen CE, Sato R (1995a) beta-Adrenergic modulation of the inwardly rectifying potassium channel in isolated human ventricular myocytes. Alteration in channel response to beta-adrenergic stimulation in failing human hearts. J Clin Invest 96:2870–2881
Koumi S, Wasserstrom JA, Ten Eick RE (1995b) beta-Adrenergic and cholinergic modulation of the inwardly rectifying K+ current in guinea-pig ventricular myocytes. J Physiol 486:647–659
Kuhlkamp V, Schirdewan A, Stangl K, Homberg M, Ploch M, Beck OA (2000) Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 36:139–146
Lakatta EG (1992) Functional implications of spontaneous sarcoplasmic reticulum Ca2+ release in the heart. Cardiovasc Res 26:193–214
Lazzara R, Scherlag BJ (1988) Generation of arrhythmias in myocardial ischemia and infarction. Am J Cardiol 61:20A–26A
Lee CO, Kang DH, Sokol JH, Lee KS (1980) Relation between intracellular Na ion activity and tension of sheep cardiac Purkinje fibers exposed to dihydro-ouabain. Biophys J 29:315–330
Leenen FH, Davies RA, Fourney A (1998) Catecholamines and heart function in heart transplant patients: effects of beta1-versus nonselective beta-blockade. Clin Pharmacol Ther 64:522–535
Li D, Melnyk P, Feng J, Wang Z, Petrecca K, Shrier A, Nattel S (2000) Effects of experimental heart failure on atrial cellular and ionic electrophysiology. Circulation 101:2631–2638
Li GR, Feng J, Wang Z, Fermini B, Nattel S (1996a) Adrenergic modulation of ultrarapid delayed rectifier K+ current in human atrial myocytes. Circ Res 78:903–915
Li GR, Feng J, Wang Z, Nattel S (1996b) Transmembrane chloride currents in human atrial myocytes. Am J Physiol 270:C500–C507
Li GR, Lau CP, Ducharme A, Tardif JC, Nattel S (2002) Transmural action potential and ionic current remodeling in ventricles of failing canine hearts. Am J Physiol Heart Circ Physiol 283:H1031–H1041
Litovsky SH, Antzelevitch C (1988) Transient outward current prominent in canine ventricular epicardium but not endocardium. Circ Res 62:116–126
Liu DW, Antzelevitch C (1995) Characteristics of the delayed rectifier current (IKr and IKs) in canine ventricular epicardial, midmyocardial, and endocardial myocytes. A weaker IKs contributes to the longer action potential of the M cell. Circ Res 76:351–365
Luo CH, Rudy Y (1994) A dynamic model of the cardiac ventricular action potential. II. Afterdepolarizations, triggered activity, and potentiation. Circ Res 74:1097–1113
Malfatto G, Rosen TS, Rosen MR (1988) The response to overdrive pacing of triggered atrial and ventricular arrhythmias in the canine heart. Circulation 77:1139–1148
Marx SO, Kurokawa J, Reiken S, Motoike H, D’Armiento J, Marks AR, Kass RS (2002) Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science 295:496–499
Matsuoka S, Ehara T, Noma A (1990) Chloride-sensitive nature of the adrenaline-induced current in guinea-pig cardiac myocytes. J Physiol 425:579–598
McDevitt DG (1989) In vivo studies on the function of cardiac beta-adrenoceptors in man. Eur Heart J 10 Suppl B:22–28
Moroni A, Gorza L, Beltrame M, Gravante B, Vaccari T, Bianchi ME, Altomare C, Longhi R, Heurteaux C, Vitadello M, Malgaroli A, DiFrancesco D (2001) Hyperpolarization-activated cyclic nucleotide-gated channel 1 is a molecular determinant of the cardiac pacemaker current I(f). J Biol Chem 276:29233–29241
Moss AJ, Zareba W, Hall WJ, Schwartz PJ, Crampton RS, Benhorin J, Vincent GM, Locati EH, Priori SG, Napolitano C, Medina A, Zhang L, Robinson JL, Timothy K, Towbin JA, Andrews ML (2000) Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation 101:616–623
Motomura S, Reinhard-Zerkowski H, Daul A, Brodde OE (1990) On the physiologic role of beta-2 adrenoceptors in the human heart: in vitro and in vivo studies. Am Heart J 119:608–619
Nakayama T, Fozzard HA (1988) Adrenergic modulation of the transient outward current in isolated canine Purkinje cells. Circ Res 62:162–172
Nattel S (2000) Acquired delayed rectifier channelopathies: how heart disease and antiarrhythmic drugs mimic potentially-lethal congenital cardiac disorders. Cardiovasc Res 48:188–190
Nattel S (2002) New ideas about atrial fibrillation 50 years on. Nature 415:219–226
Nattel S (2003) Rhythm versus rate control for atrial fibrillation management: what recent randomized clinical trials allow us to affirm. CMAJ 168:572–573
Nattel S, Li D (2000) Ionic remodeling in the heart: pathophysiological significance and new therapeutic opportunities for atrial fibrillation. Circ Res 87:440–447
Nattel S, Quantz MA (1988) Pharmacological response of quinidine induced early afterdepolarisations in canine cardiac Purkinje fibres: insights into underlying ionic mechanisms. Cardiovasc Res 22:808–817
Nattel S, Waters D (1990) What is anantiarrhythmic drug? From clinical trials to fundamental concepts. Am J Cardiol 66:96–99
Nattel S, Khairy P, Roy D, Thibault B, Guerra P, Talajic M, Dubuc M (2002) New approaches to atrial fibrillation management: a critical review of a rapidly evolving field. Drugs 62:2377–2397
Nordin C, Siri F, Aronson RS (1989) Electrophysiologic characteristics of single myocytes isolated from hypertrophied guinea-pig hearts. J Mol Cell Cardiol 21:729–739
Nuttall A, Snow HM (1982) The cardiovascular effects of ICI 118,587: A beta 1-adrenoceptor partial agonist. Br J Pharmacol 77:381–388
Oral H, Chugh A, Scharf C, Hall B, Cheung P, Veerareddy S, Daneshvar GF, Pelosi F Jr, Morady F (2004) Pulmonary vein isolation for vagotonic, adrenergic, and random episodes of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 15:402–406
Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 334:1349–1355
Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Roecker EB, Schultz MK, DeMets DL (2001) Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344:1651–1658
Pappone C, Rosanio S, Oreto G, Tocchi M, Gugliotta F, Vicedomini G, Salvati A, Dicandia C, Mazzone P, Santinelli V, Gulletta S, Chierchia S (2000) Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation. Circulation 102:2619–2628
Plank DM, Yatani A, Ritsu H, Witt S, Glascock B, Lalli MJ, Periasamy M, Fiset C, Benkusky N, Valdivia HH, Sussman MA (2003) Calcium dynamics in the failing heart: restoration by beta-adrenergic receptor blockade. Am J Physiol Heart Circ Physiol 285:H305–H315
Pogwizd SM, Bers DM (2004) Cellular basis of triggered arrhythmias in heart failure. Trends Cardiovasc Med 14:61–66
Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, Lubsen J, Lutiger B, Metra M, Remme WJ, Torp-Pedersen C, Scherhag A, Skene A (2003) Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 362:7–13
Priori SG, Napolitano C (2004) Genetics of cardiac arrhythmias and sudden cardiac death. Ann N Y Acad Sci 1015:96–110
Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, Sorrentino V, Danieli GA (2001) Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103:196–200
Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, White R, Furberg CD, Rautaharju PM (1997) Incidence of and risk factors for atrial fibrillation in older adults. Circulation 96:2455–2461
Reddy P (2001) Does prophylaxis against atrial fibrillation after cardiac surgery reduce length of stay or hospital costs? Pharmacotherapy 21:338–344
Reiter MJ (2002) Beta-adrenergic blocking drugs as antifibrillatory agents. Curr Cardiol Rep 4:426–433
Reiter MJ, Reiffel JA (1998) Importance of beta blockade in the therapy of serious ventricular arrhythmias. Am J Cardiol 82:9I–19I
Rodefeld MD, Beau SL, Schuessler RB, Boineau JP, Saffitz JE (1996) Beta-adrenergic and muscarinic cholinergic receptor densities in the human sinoatrial node: identification of a high beta 2-adrenergic receptor density. J Cardiovasc Electrophysiol 7:1039–1049
Roden DM (2004) Drug-induced prolongation of the QT interval. N Engl J Med 350:1013–1022
Rosati B, Grau F, Rodriguez S, Li H, Nerbonne JM, McKinnon D (2003) Concordant expression of KChIP2 mRNA, protein and transient outward current throughout the canine ventricle. J Physiol 548:815–822
Rossner KL, Sachs HG (1978) Electrophysiological study of Syrian hamster hereditary cardiomyopathy. Cardiovasc Res 12:436–443
Ryden L, Ariniego R, Arnman K, Herlitz J, Hjalmarson A, Holmberg S, Reyes C, Smedgard P, Svedberg K, Vedin A, Waagstein F, Waldenstrom A, Wilhelmsson C, Wedel H, Yamamoto M (1983) A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias. N Engl J Med 308:614–618
Sanguinetti MC, Curran ME, Zou A, Shen J, Spector PS, Atkinson DL, Keating MT (1996) Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature 384:80–83
Schafers RF, Poller U, Ponicke K, Geissler M, Daul AE, Michel MC, Brodde OE (1997) Influence of adrenoceptor and muscarinic receptor blockade on the cardiovascular effects of exogenous noradrenaline and of endogenous noradrenaline released by infused tyramine. Naunyn Schmiedebergs Arch Pharmacol 355:239–249
Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, Denjoy I, Guicheney P, Breithardt G, Keating MT, Towbin JA, Beggs AH, Brink P, Wilde AA, Toivonen L, Zareba W, Robinson JL, Timothy KW, Corfield V, Wattanasirichaigoon D, Corbett C, Haverkamp W, Schulze-Bahr E, Lehmann MH, Schwartz K, Coumel P, Bloise R (2001) Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 103:89–95
Shand DG (1983) Clinical pharmacology of the beta-blocking drugs: implications for the postinfarction patient. Circulation 67:I2–I5
Shimizu W, Noda T, Takaki H, Kurita T, Nagaya N, Satomi K, Suyama K, Aihara N, Kamakura S, Sunagawa K, Echigo S, Nakamura K, Ohe T, Towbin JA, Napolitano C, Priori SG (2003) Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. J Am Coll Cardiol 41:633–642
Sicouri S, Antzelevitch C (1995) Electrophysiologic characteristics of M cells in the canine left ventricular free wall. J Cardiovasc Electrophysiol 6:591–603
Singh BN, Vaughan Williams EM (1970) A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474. Br J Pharmacol 39:675–687
Sinno H, Derakhchan K, Libersan D, Merhi Y, Leung TK, Nattel S (2003) Atrial ischemia promotes atrial fibrillation in dogs. Circulation 107:1930–1936
Sneader W (2001) The discovery and synthesis of epinephrine. Drug News Perspect 14:491–494
Soriano JB, Hoes AW, Meems L, Grobbee DE (1997) Increased survival with beta-blockers: importance of ancillary properties. Prog Cardiovasc Dis 39:445–456
St John SM, Ferrari VA (2002) Prevention of left ventricular remodeling after myocardial infarction. Curr Treat Options Cardiovasc Med 4:97–108
Steinfath M, Danielsen W, von der LH, Mende U, Meyer W, Neumann J, Nose M, Reich T, Schmitz W, Scholz H (1992) Reduced alpha 1-and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure. Br J Pharmacol 105:463–469
Stengl M, Volders PG, Thomsen MB, Spatjens RL, Sipido KR, Vos MA (2003) Accumulation of slowly activating delayed rectifier potassium current (IKs) in canine ventricular myocytes. J Physiol 551:777–786
Sumitomo N, Harada K, Nagashima M, Yasuda T, Nakamura Y, Aragaki Y, Saito A, Kurosaki K, Jouo K, Koujiro M, Konishi S, Matsuoka S, Oono T, Hayakawa S, Miura M, Ushinohama H, Shibata T, Niimura I (2003) Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. Heart 89:66–70
Thomas D, Zhang W, Karle CA, Kathofer S, Schols W, Kubler W, Kiehn J (1999) Deletion of protein kinase A phosphorylation sites in the HERG potassium channel inhibits activation shift by protein kinase A. J Biol Chem 274:27457–27462
Tromba C, Cohen IS (1990) A novel action of isoproterenol to inactivate a cardiac K+ current is not blocked by beta and alpha adrenergic blockers. Biophys J 58:791–795
Ullman A, Svedmyr N (1988) Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients. Thorax 43:674–678
Ungerer M, Bohm M, Elce JS, Erdmann E, Lohse MJ (1993) Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation 87:454–463
Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ (2002) A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347:1834–1840
Viatchenko-Karpinski S, Terentyev D, Gyorke I, Terentyeva R, Volpe P, Priori SG, Napolitano C, Nori A, Williams SC, Gyorke S (2004) Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin. Circ Res 94:471–477
Volders PG, Sipido KR, Carmeliet E, Spatjens RL, Wellens HJ, Vos MA (1999) Repolarizing K+ currents ITO1 and IKs are larger in right than left canine ventricular midmyocardium. Circulation 99:206–210
Volders PG, Stengl M, van Opstal JM, Gerlach U, Spatjens RL, Beekman JD, Sipido KR, Vos MA (2003) Probing the contribution of IKs to canine ventricular repolarization: key role for beta-adrenergic receptor stimulation. Circulation 107:2753–2760
Vos MA, Gorgels AP, Leunissen JD, Wellens HJ (1990) Flunarizine allows differentiation between mechanisms of arrhythmias in the intact heart. Circulation 81:343–349
Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA, Gilbert EM, Johnson MR, Goss FG, Hjalmarson A (1993) Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet 342:1441–1446
Wainger BJ, DeGennaro M, Santoro B, Siegelbaum SA, Tibbs GR (2001) Molecular mechanism of cAMP modulation of HCN pacemaker channels. Nature 411:805–810
Waldo AL, Camm AJ, deRuyter H, Friedman PL, MacNeil DJ, Pauls JF, Pitt B, Pratt CM, Schwartz PJ, Veltri EP (1996) Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. Lancet 348:7–12
Walsh KB, Kass RS (1991) Distinct voltage-dependent regulation of a heart-delayed IK by protein kinases A and C. Am J Physiol 261:C1081–C1090
Wang Z, Fermini B, Nattel S (1993) Sustained depolarization-induced outward current in human atrial myocytes. Evidence for a novel delayed rectifier K+ current similar to Kv1 5 cloned channel currents. Circ Res 73:1061–1076
Warth JD, Collier ML, Hart P, Geary Y, Gelband CH, Chapman T, Horowitz B, Hume JR (1996) CFTR chloride channels in human and simian heart. Cardiovasc Res 31:615–624
Wettwer E, Amos GJ, Posival H, Ravens U (1994) Transient outward current in human ventricular myocytes of subepicardial and subendocardial origin. Circ Res 75:473–482
Wiederhold KF, Nilius B (1986) Increased sensitivity of ventricular myocardium to intracellular calcium-overload in Syrian cardiomyopathic hamster. Biomed Biochim Acta 45:1333–1337
Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA (1995) Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 92:1954–1968
Wilde AA, Roden DM (2000) Predicting the long-QT genotype from clinical data: from sense to science. Circulation 102:2796–2798
Williams RS, Bishop T (1981) Selectivity of dobutamine for adrenergic receptor subtypes: in vitro analysis by radioligand binding. J Clin Invest 67:1703–1711
Wischmeyer E, Karschin A (1996) Receptor stimulation causes slow inhibition of IRK1 inwardly rectifying K+ channels by direct protein kinase A-mediated phosphorylation. Proc Natl Acad Sci U S A 93:5819–5823
Wit AL, Cranefield PF (1976) Triggered activity in cardiac muscle fibers of the simian mitral valve. Circ Res 38:85–98
Wit AL, Cranefield PF (1977) Triggered and automatic activity in the canine coronary sinus. Circ Res 41:434–445
Woelfel A, Foster JR, Simpson RJ Jr, Gettes LS (1984) Reproducibility and treatment of exercise-induced ventricular tachycardia. Am J Cardiol 53:751–756
Workman AJ, Kane KA, Russell JA, Norrie J, Rankin AC (2003) Chronic beta-adrenoceptor blockade and human atrial cell electrophysiology: evidence of pharmacological remodelling. Cardiovasc Res 58:518–525
Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD (2002) A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347:1825–1833
Xiao YF, McArdle JJ (1995) Activation of protein kinase A partially reverses the effects of 2,3-butanedione monoxime on the transient outward K+ current of rat ventricular myocytes. Life Sci 57:335–343
Yasumura Y, Takemura K, Sakamoto A, Kitakaze M, Miyatake K (2003) Changes in myocardial gene expression associated with beta-blocker therapy in patients with chronic heart failure. J Card Fail 9:469–474
Yue L, Melnyk P, Gaspo R, Wang Z, Nattel S (1999) Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation. Circ Res 84:776–784
Yusuf S, Peto R, Lewis J, Collins R, Sleight P (1985) Beta blockade during and aftermyocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 27:335–371
Zhang LM, Wang Z, Nattel S (2002) Effects of sustained beta-adrenergic stimulation on ionic currents of cultured adult guinea pig cardiomyocytes. Am J Physiol Heart Circ Physiol 282:H880–H889
Zipes DP, Arbel E, Knope RF, Moe GK (1974) Accelerated cardiac escape rhythms caused by ouabain intoxication. Am J Cardiol 33:248–253
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Priori, S., Napolitano, C., Cerrone, M. (2006). β-Blockers as Antiarrhythmic Agents. In: Basis and Treatment of Cardiac Arrhythmias. Handbook of Experimental Pharmacology, vol 171. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-29715-4_9
Download citation
DOI: https://doi.org/10.1007/3-540-29715-4_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-24967-2
Online ISBN: 978-3-540-29715-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)